3M Company Company Profile and SWOT Analysis 3M Company 3M

Document Sample
3M Company Company Profile and SWOT Analysis 3M Company 3M Powered By Docstoc
					3M Company

_________________________________________________________________________________



3M Company                                                                           Financial Snapshot

                                                                                     Operating Performance
Fast Facts
                                       3M Center, St. Paul, 55144,United States of   The company reported revenues of US$26,662.00
Headquarters Address
                                       America                                       million during 2010, with a CAGR of 3.85% during
                                                                                     2006–2010. Its revenue grew at an annual rate of
Telephone                              + 1 651 7331110
                                                                                     15.31% over the previous fiscal year. In 2010, the
                                                                                     company recorded an operating margin of 22.20%, as
Fax                                    + 1 651 7339973                               against 20.82% in 2009.

Website                                www.3m.com
                                                                                     Revenue and Margins
Ticker Symbol, Stock Exchange          MMM, New York Stock Exchange

Number of Employees                    74,835

Fiscal Year End                        December

Revenue (in US$ million)               26,662.00




SWOT Analysis

Strengths                              Weaknesses                                    Return on Equity

Improving Liquidity Position           Decline in Revenue                            The company recorded a return on equity (ROE) of
                                                                                     26.08% for 2010, as compared to its peers, Baxter
                                       Respirator Mask and Asbestos                  International Inc. (Ticker: BAX), DENTSPLY
Improving Operating Margin                                                           International Inc. (Ticker: XRAY) and Nobel Biocare
                                       Litigation
                                                                                     Holding AG (Ticker: NOBN), which recorded ROEs of
Strengthening Solvency Position                                                      21.62%, 14.45% and 14.27% respectively. The
                                                                                     company reported an operating margin of 22.20% in
                                                                                     2010.
Opportunities                          Threats
Increasing demand for LCD TV and                                                     Return on Equity
                                       Environmental Regulations
Laptops

Positive Outlook of Automotive Industry Negative Construction Outlook for US

Remodeling Business In the US          Rising Labor Cost




                                                                                     Liquidity Position

                                                                                     The company reported a current ratio of 2.01 in 2010,
                                                                                     as compared to its peers, Baxter International Inc.,
                                                                                     DENTSPLY International Inc. and Nobel Biocare
                                                                                     Holding AG, which recorded current ratios of 1.98,
                                                                                     3.65 and 1.03 respectively. As of December 2010, the
                                                                                     company recorded cash and short-term investments
                                                                                     of worth US$4,478.00 million, against zero current
                                                                                     debt. The company reported a debt to equity ratio of
                                                                                     0.35 in 2010 as compared to its peers, Baxter
                                                                                     International Inc., DENTSPLY International Inc. and
                                                                                     Nobel Biocare Holding AG, which recorded debt to
                                                                                     equity ratios of 0.67, 0.33 and 0.79 respectively.




___________________________________________________________________________________________

3M Company - SWOT Profile                                                                                                   Page 1
3M Company

_________________________________________________________________________________


TABLE OF CONTENTS

1     Business Analysis ................................................................................................................................... 5
    1.1       Company Overview ................................................................................................................................................5
    1.2       Business Description ..............................................................................................................................................5
    1.3       Major Products and Services .................................................................................................................................6
2     Analysis of Key Performance Indicators ............................................................................................... 9
    2.1       Five Year Snapshot: Overview of Financial and Operational Performance Indicators ..........................................9
    2.2       Key Financial Performance Indicators .................................................................................................................12
      2.2.1       Revenue and Operating Profit .........................................................................................................................12
      2.2.2       Asset, Liabilities and Capex .............................................................................................................................13
      2.2.3       Net Debt vs. Gearing Ratio ..............................................................................................................................14
      2.2.4       Operational Efficiency ......................................................................................................................................15
      2.2.5       Solvency ..........................................................................................................................................................16
      2.2.6       Valuation ..........................................................................................................................................................17
    2.3       Competitive Benchmarking ..................................................................................................................................18
      2.3.1       Market Capitalization .......................................................................................................................................18
      2.3.2       Efficiency ..........................................................................................................................................................19
      2.3.3       Capital Expenditure..........................................................................................................................................20
      2.3.4       Valuation ..........................................................................................................................................................21
      2.3.5       Turnover – Inventory and Asset .......................................................................................................................22
      2.3.6       Liquidity ............................................................................................................................................................23
3     Mergers & Acquisitions and Partnerships ........................................................................................... 24
    3.1       M&A and Partnerships Strategy ...........................................................................................................................24
4     Recent Developments ...................................................................................
				
DOCUMENT INFO
Description: This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business. ICD Research's "3M Company: Company Profile and SWOT Analysis" report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
BUY THIS DOCUMENT NOW PRICE: $99 100% MONEY BACK GUARANTEED
PARTNER ICD Research
With emphasis on Insight, Consultancy and Delivery, iCD Research is a full-service, online market research agency. iCD Research is able to take advantage of all of the efficiencies and benefits that the Internet brings to offer proven research methodologies with fast turnaround and accurate results. iCD Research specialises in qualitative research for large finance, media, retail and entertainment clients. Market leaders in online focus groups, iCD Research has unleashed the full scale of the Internet to run focus groups across the globe for its major institutional clients. Utilising its sister organisation, The iD Factor, iCD Research also delivers strong quantitative research, ranging from ongoing consumer confidence studies through to consumer surveys throughout Europe and Asia. With its roots firmly in research, iCD Research doesn’t limit itself to only utilising online methods as the philosophy at the company is to match the methodology to the respondent. Yet the scale and speed of online research give iCD Research a cutting edge that has lead to tremendous, triple-figure percentage growth over the past two years. iCD Research is headquartered in London, with operational offices in the US and Australia to ensure that it is offering an unparalleled 24 hour service to its clients.